USP39 is recruited by dynein axonemal assembly factor 5 (DNAAF5), and stabilize phosphofructokinase L (PFKL) through the deubiquitination pathway, thereby promoting HCC proliferation and resistance to sorafenib150. Here, USP39 is linked to hepatocellular carcinoma.